Explore

Capbase

LYNCH REGENERATIVE MEDICINE, LLC — Funding, Investors & Profile — Capbase

Private

Private securities offering disclosed via SEC Form D.

Other Health Care

$15MSource: [SEC]Total raised

UndisclosedSource: [SEC]Last valuation

LYNCH REGENERATIVE MEDICINE, LLC filed a Form D notice of exempt offering with the SEC.

1 rounds

1 round · latest Private placement (Form D), Jun 2026 · $15M raised

No investors recorded yet for LYNCH REGENERATIVE MEDICINE, LLC.

Leadership

SAMUEL LYNCHExecutive OfficerSince 2026Source: [SEC]

LYNCH REGENERATIVE MEDICINE, LLC has no recorded acquisitions.

Still private — no exit on record.

No diversity signals recorded yet for LYNCH REGENERATIVE MEDICINE, LLC.

Data aggregated from SEC EDGAR, Wikidata, and community contributions. Spotted an error? Propose a change or report an issue.

Series A

Sector

Healthcare